Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/21366910

Download in:

View as

General Info

PMID
21366910